{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:45:27Z","timestamp":1788403527180,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BIOLOGIA FUTURA"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19 is a disease-causing current pandemic. It prevails in patients with pre-existing conditions such as diabetes and hypertension. Renin\u2013angiotensin system was identified as a center of COVID-19 pathophysiology. There is a current controversy concerning the usage of ACE inhibitors and AR blockers in patients with COVID-19. Multiple clinical trials are on the way to determine the effect of RAS blockers in patients with COVID-19. ACE2 receptor is thought to be the point of entry utilized by a coronavirus. However, other factors have been identified which potentially facilitate SARS-CoV-2 entry into the cell. ADAM17 could facilitate viral entry in hyperglycemic and diabetic patients. Insulin is an ADAM17 inhibitor. Heme oxygenase (HO)-1 level is reduced in diabetic patients, contributing to the worst outcome for patients with poor glycemic control. The combined therapy of glycemic control and antioxidant response to oxidative stress could be explored in patients with COVID-19.<\/jats:p>","DOI":"10.1007\/s42977-021-00092-2","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T12:04:00Z","timestamp":1623153840000},"page":"291-297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Biologia Futura: is ADAM 17 the reason for COVID-19 susceptibility in hyperglycemic and diabetic patients?"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8285-2762","authenticated-orcid":false,"given":"Ganna","family":"Stepanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,8]]},"reference":[{"key":"92_CR1","doi-asserted-by":"publisher","unstructured":"Callejas Rubio JL, Aomar Millan I, Moreno-Higueras M, Mart\u00edn Ripoll L, Yuste Osorio E, R\u00edos-Fern\u00e1ndez R (2021) Precauci\u00f3n con el uso de dexametasona en pacientes con COVID-19 en sus fases iniciales. Rev Cl\u00edn Esp, ISSN 0014-2565. https:\/\/doi.org\/10.1016\/j.rce.2021.02.001","DOI":"10.1016\/j.rce.2021.02.001"},{"key":"92_CR2","doi-asserted-by":"publisher","first-page":"104903","DOI":"10.1016\/j.phrs.2020.104903","volume":"158","author":"LA Cal\u00f2","year":"2020","unstructured":"Cal\u00f2 LA, Bertoldi G, Davis PA (2020) Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: support from bartter\u2019s and gitelman\u2019s syndrome patients. Pharmacol Res 158:104903","journal-title":"Pharmacol Res"},{"issue":"6518","key":"92_CR3","doi-asserted-by":"publisher","first-page":"856 LP\u2013860","DOI":"10.1126\/science.abd2985","volume":"370","author":"L Cantuti-Castelvetri","year":"2020","unstructured":"Cantuti-Castelvetri L, Ojha R, Pedro L, Djannatian M, Franz J, Kuivanen S, Kallio K, Kaya T, Anastasina M, Smura T, Levanov L, Szirovicza L, Tobi A, Kallio-Kokko H, \u00d6sterlund P, Joensuu M, Meunier F, Butcher S, Winkler MS, Mollenhauer B, Helenius A, Gokce O, Teesalu T, Hepojoki J, Vapalahti O, Stadelmann C, Balistreri G, Simons M (2020) Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system. Science 370(6518):856 LP\u2013860. https:\/\/doi.org\/10.1126\/science.abd2985","journal-title":"Science"},{"issue":"3","key":"92_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2174\/1871526520999200505174704","volume":"20","author":"Z Cao","year":"2020","unstructured":"Cao Z, Wu Y, Faucon E, Sabatier JM (2020) SARS-CoV-2 & Covid-19: key-roles of the \u2018renin-angiotensin\u2019 system\/vitamin D impacting drug and vaccine developments. Inf Disord Drug Targets 20(3):348\u2013349","journal-title":"Inf Disord Drug Targets"},{"issue":"10","key":"92_CR5","first-page":"1951","volume":"22","author":"A Ceriello","year":"2020","unstructured":"Ceriello A, De Nigris V, Prattichizzo F (2020) Why Is hyperglycaemia worsening COVID-19 and its prognosis? DOM 22(10):1951\u20131952","journal-title":"DOM"},{"issue":"4","key":"92_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","volume":"183","author":"TM Clausen","year":"2020","unstructured":"Clausen TM, Sandova D, Spliid C, Pihl J, Painter C, Thacker B, Glass C, Narayanan A, Majowicz S, Zhang Y, Torres J, Golden G, Porell R, Garretson A, Laubach L, Feldman J, Yin X, Pu Y, Hauser B, Caradonna T, Kellman B, Martino C, Gordts P, Leibel S, Chanda S, Schmidt A, Godula K, Jose J, Corbett K, Ward A, Carlin A, Esko J (2020) SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183(4):1043\u20131057.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.09.033","journal-title":"Cell"},{"key":"92_CR7","doi-asserted-by":"publisher","DOI":"10.1109\/TCBB.2020.3009099","author":"C Cui","year":"2020","unstructured":"Cui C, Huang C, Zhou W, Ji X, Zhang F, Wang L, Zhou Y, Cui Q (2020) AGTR2, One possible novel key gene for the entry of SARS-CoV-2 into human cells. IEEE\/ACM Trans Comput Biol Bioinf. https:\/\/doi.org\/10.1109\/TCBB.2020.3009099","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"key":"92_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1126\/science.abd3072","volume":"307","author":"JL Daly","year":"2020","unstructured":"Daly JL, Simonetti B, Klein K, Chen KE, Williamson MK, Ant\u00f3n-Pl\u00e1garo C, Shoemark DK, Sim\u00f3n-Gracia L, Baue M, Hollandi R, Greber UF, Horvath P, Sessions RB, Helenius A, Hiscox JA, Teesalu T, Matthews DA, Davidson AD, Collins BM, Cullen PJ, Yamauchi Y (2020) Neuropilin-1 Is a host factor for SARS-CoV-2 infection. Science 307:861\u2013865","journal-title":"Science"},{"issue":"6","key":"92_CR9","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","volume":"75","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertens (Dallas, Tex: 1979) 75(6):1382\u20131385","journal-title":"Hypertens (Dallas, Tex: 1979)"},{"issue":"10238","key":"92_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(20)31030-8","volume":"395","author":"FJ de Abajo","year":"2020","unstructured":"de Abajo FJ, Rodr\u00edguez-Mart\u00edn S, Lerma V, Mej\u00eda-Abril G, Aguilar M, Garc\u00eda-Luque A, Laredo L, Laosa O, Centeno-Soto GA, \u00c1ngeles G\u00e1lvez M, Puerro M, Gonz\u00e1lez-Rojano E, Pedraza L, de Pablo I, Abad-Santos F, Rodr\u00edguez-Ma\u00f1as L, Gil M, Tob\u00edas A, Rodr\u00edguez-Miguel A, Rodr\u00edguez-Puyol D, Barreira-Hernandez D, Zubiaur P, Santos-Molina E, Pintos-S\u00e1nchez E, Navares-G\u00f3mez M, Aparicio RM, Garc\u00eda-Rosado V, Guti\u00e9rrez-Ortega C, P\u00e9rez C, Ascaso A, Elvira C (2020) Use of renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of covid-19 requiring admission to hospital: a case-population study. Lancet 395(10238):1705\u20131714","journal-title":"Lancet"},{"issue":"10","key":"92_CR11","first-page":"891","volume":"34","author":"W Ding","year":"2018","unstructured":"Ding W, Li X, Wu W, He H, Li Y, Gao L, Gan L, Wang M, Ou S, Liu J (2018) Aliskiren inhibits angiotensin II\/angiotensin 1\u20137Ang II\/Ang1\u20137 signal pathway in rats with diabetic nephropathy. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = CJCMImmun 34(10):891\u2013895","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = CJCMImmun"},{"issue":"3","key":"92_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/endrev\/bnaa011","volume":"41","author":"DJ Drucker","year":"2020","unstructured":"Drucker DJ (2020) Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications. Endocr Rev 41(3):457\u2013470","journal-title":"Endocr Rev"},{"issue":"10","key":"92_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY (2020) Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 126(10):1456\u20131474","journal-title":"Circ Res"},{"issue":"2","key":"92_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/10409231003628015","volume":"45","author":"M Gooz","year":"2010","unstructured":"Gooz M (2010) ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 45(2):146\u2013169","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"5","key":"92_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/ddr.21656","volume":"81","author":"D Gurwitz","year":"2020","unstructured":"Gurwitz D (2020) Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res 81(5):537\u2013540","journal-title":"Drug Dev Res"},{"issue":"22","key":"92_CR60","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","volume":"105","author":"S Haga","year":"2008","unstructured":"Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, Sata T, Yamamoto N, Sasazuki T, Ishizaka Y (2008) Modulation of TNF-\u03b1-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-\u03b1 production and facilitates viral entry. Proc Natl Acad Sci 105(22):7809\u20137814","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"92_CR16","first-page":"244","volume":"26","author":"HA Hakeam","year":"2020","unstructured":"Hakeam HA, Alsemari M, Al Duhailib Z, Ghonem L, Alharbi SA, Almutairy E, Bin Sheraim NM, Alsalhi M, Alhijji A, AlQahtani S, Khalid M, Barry M (2020) Association of angiotensin-converting enzyme inhibitors and angiotensin II blockers with severity of COVID-19: A multicenter prospective study. JCPT 26(3):244\u2013252","journal-title":"JCPT"},{"issue":"11","key":"92_CR17","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1111\/j.1742-4658.2006.05224.x","volume":"273","author":"EM Harrison","year":"2006","unstructured":"Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ (2006) Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-Kinase\/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J 273(11):2345\u20132356","journal-title":"FEBS J"},{"issue":"5","key":"92_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.jinf.2020.02.026","volume":"80","author":"IM Ibrahim","year":"2020","unstructured":"Ibrahim IM, Abdelmalek DH, Elshahat ME, Elfiky AA (2020) COVID-19 spike-host cell receptor GRP78 binding site prediction. J Inf 80(5):554\u2013562","journal-title":"J Inf"},{"issue":"10","key":"92_CR19","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1016\/j.jmb.2020.04.009","volume":"432","author":"JA Jaimes","year":"2020","unstructured":"Jaimes JA, Andr\u00e9 NM, Chappie JS, Millet JK, Whittaker GR (2020) Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop. J Mol Biol 432(10):3309\u20133325","journal-title":"J Mol Biol"},{"issue":"16","key":"92_CR20","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1093\/cid\/ciaa624","volume":"71","author":"SY Jung","year":"2020","unstructured":"Jung SY, Chol Choi J, You S-H, Kim W-Y (2020) Association of renin-angiotensin-aldosterone system inhibitors with COVID19-related outcomes in Korea: a nationwide population-based cohort study. Clin Inf Disease 71(16):2121\u20132128. https:\/\/doi.org\/10.1093\/cid\/ciaa624","journal-title":"Clin Inf Disease"},{"key":"92_CR21","first-page":"173","volume":"56","author":"G Kasinathan","year":"2020","unstructured":"Kasinathan G, Sathar J (2020) Haematological manifestations, mechanisms of thrombosis and anti-coagulation in COVID-19 disease: a review. AMS 56:173\u2013177","journal-title":"AMS"},{"issue":"4","key":"92_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00059-020-04920-4","volume":"45","author":"T Kessler","year":"2020","unstructured":"Kessler T, Schunkert H (2020) Inhibitors of the renin-angiotensin system and SARS-CoV-2 infection. Herz 45(4):323\u2013324","journal-title":"Herz"},{"issue":"35","key":"92_CR23","doi-asserted-by":"publisher","first-page":"21603","DOI":"10.1074\/jbc.M115.651604","volume":"290","author":"R Li","year":"2015","unstructured":"Li R, Uttarwar L, Gao B, Charbonneau M, Shi Y, Chan JSD, Dubois CM, Krepinsky JC (2015) High glucose up-regulates ADAM17 through HIF-1\u03b1 in mesangial cells. JBC 290(35):21603\u201321614","journal-title":"JBC"},{"issue":"7","key":"92_CR24","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/hr.2016.17","volume":"39","author":"H Lu","year":"2016","unstructured":"Lu H, Cassis LA, Vander Kooi CW, Daugherty A (2016) Structure and functions of angiotensinogen. Hypert Res 39(7):492\u2013500","journal-title":"Hypert Res"},{"issue":"9","key":"92_CR25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","volume":"5","author":"N Mehta","year":"2020","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK (2020) Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(9):1020","journal-title":"JAMA Cardiol"},{"issue":"1","key":"92_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, Yang R, Di W, Wang Z, Li Z, Gao H, Liu L, Zhang G (2020) Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect 9(1):757\u2013760","journal-title":"Emerg Microbes Infect"},{"issue":"6","key":"92_CR27","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S2213-2600(20)30224-1","volume":"8","author":"S Milne","year":"2020","unstructured":"Milne S, Yang CX, Timens W, Boss\u00e9 Y, Sin DD (2020) SARS-CoV-2 receptor ACE2 Gene expression and RAAS INHIBITORS. Lancet Respir Med 8(6):e50-51","journal-title":"Lancet Respir Med"},{"issue":"4","key":"92_CR28","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.dsx.2020.04.040","volume":"14","author":"A Nakhleh","year":"2020","unstructured":"Nakhleh A, Shehadeh N (2020) Interactions between antihyperglycemic drugs and the renin-angiotensin system: putative roles in COVID-19. A mini-review. Diabetes Metab Syndr Clin Res Rev 14(4):509\u2013512","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"4","key":"92_CR29","first-page":"351","volume":"49","author":"MB Omar","year":"2020","unstructured":"Omar MB (2020) Covid-19 and the angiotensin-converting enzyme (ACE2): areas for research. AAHFN 49(4):351","journal-title":"AAHFN"},{"issue":"4","key":"92_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.dsx.2020.04.049","volume":"14","author":"R Pal","year":"2020","unstructured":"Pal R, Bhadada SK (2020a) COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes Metab Syndr Clin Res Rev 14(4):513\u2013517","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"92_CR31","first-page":"108146","volume":"163","author":"R Pal","year":"2020","unstructured":"Pal R, Bhadada SK (2020b) Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? DRCP 163:108146","journal-title":"DRCP"},{"issue":"6","key":"92_CR32","first-page":"1071","volume":"35","author":"V Palau","year":"2020","unstructured":"Palau V, Riera M, Soler MJ (2020) ADAM17 inhibition may exert a protective effect on COVID-19. NDT 35(6):1071\u20131072","journal-title":"NDT"},{"key":"92_CR33","first-page":"108220","volume":"164","author":"D Pitocco","year":"2020","unstructured":"Pitocco D, Tartaglione L, Viti L, Di Leo M, Manto A, Caputo S, Pontecorvi A (2020) Lack of type 1 diabetes involvement in SARS-COV-2 population: only a particular coincidence? DRCP 164:108220","journal-title":"DRCP"},{"issue":"20","key":"92_CR34","doi-asserted-by":"publisher","first-page":"E553","DOI":"10.1503\/cmaj.200619","volume":"192","author":"KL Quinn","year":"2020","unstructured":"Quinn KL, Fralick M, Zipursky JS, Stall NM (2020) Renin-angiotensin-aldosterone system inhibitors and COVID-19. CMAJ 192(20):E553\u2013E554","journal-title":"CMAJ"},{"key":"92_CR35","doi-asserted-by":"publisher","first-page":"109686","DOI":"10.1016\/j.mehy.2020.109686","volume":"140","author":"L Roncati","year":"2020","unstructured":"Roncati L, Gallo G, Manenti A, Palmieri B (2020) Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2. Med Hypothese 140:109686","journal-title":"Med Hypothese"},{"issue":"2","key":"92_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/0897190020979608","volume":"34","author":"MA Salem","year":"2020","unstructured":"Salem MA (2020) A response to the recommendations for using dexamethasone for the treatment of COVID-19: the dark side of dexamethasone. J Pharm Pract 34(2):179\u2013180. https:\/\/doi.org\/10.1177\/0897190020979608","journal-title":"J Pharm Pract"},{"key":"92_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1152\/ajprenal.00516.2013","volume":"306","author":"ESB Salem","year":"2014","unstructured":"Salem ESB, Grobe N, Elased KM (2014) Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic akita mice. Am J Physiol Ren Physiol 306:629\u2013639","journal-title":"Am J Physiol Ren Physiol"},{"issue":"5","key":"92_CR38","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/jcm9051417","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G (2020) Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med 9(5):1417","journal-title":"J Clin Med"},{"key":"92_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fmed.2019.00107","volume":"6","author":"J Schleifenbaum","year":"2019","unstructured":"Schleifenbaum J (2019) Alamandine and its receptor MrgD pair up to join the protective arm of the renin-angiotensin system. Front Med 6:107","journal-title":"Front Med"},{"issue":"02","key":"92_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4236\/jdm.2013.32011","volume":"03","author":"S Siewert","year":"2013","unstructured":"Siewert S, Gonz\u00e1lez I, Santill\u00e1n L, Lucero R, Ojeda MS, Gimenez MS (2013) Downregulation of Nrf2 and HO-1 expression contributes to oxidative stress in Type 2 diabetes mellitus: a study in juana Koslay City, San Luis, Argentina. JDM 03(02):71\u201378","journal-title":"JDM"},{"issue":"6","key":"92_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ddr.21672","volume":"81","author":"RC Speth","year":"2020","unstructured":"Speth RC (2020) Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections. Drug Dev Res 81(6):643\u2013646","journal-title":"Drug Dev Res"},{"issue":"2","key":"92_CR42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/cpt.1863","volume":"108","author":"K Sriram","year":"2020","unstructured":"Sriram K, Insel PA (2020) Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence. Clin Pharmacol Ther 108(2):236\u2013241","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"92_CR43","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1053\/j.gastro.2020.05.034","volume":"159","author":"N-D Tan","year":"2020","unstructured":"Tan N-D, Qiu Y, Xing X-B, Ghosh S, Chen M-H, Mao R (2020) Associations between angiotensin-converting enzyme inhibitors and angiotensin II receptor blocker use, gastrointestinal symptoms, and mortality among patients with COVID-19. Gastroenterol 159(3):1170-1172.e1","journal-title":"Gastroenterol"},{"key":"92_CR44","doi-asserted-by":"publisher","first-page":"109795","DOI":"10.1016\/j.mehy.2020.109795","volume":"142","author":"P Tatti","year":"2020","unstructured":"Tatti P, Tonolo G, Zanfardino A, Iafusco D (2020) Is it fair to hope that patients with type 1 diabetes (Autoimmune) may be spared by the infection of Covid-19? Med Hypothese 142:109795","journal-title":"Med Hypothese"},{"issue":"6","key":"92_CR45","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3390\/antiox9060540","volume":"9","author":"FADTG Wagener","year":"2020","unstructured":"Wagener FADTG, Pickkers P, Peterson SJ, Immenschuh S, Abraham NG (2020) Targeting the heme-heme oxygenase system to prevent severe complications following COVID-19 infections. Antioxid 9(6):540","journal-title":"Antioxid"},{"issue":"1","key":"92_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","volume":"121","author":"J Xu","year":"2017","unstructured":"Xu J, Sriramula S, Xia H, Moreno-Walton L, Culicchia F, Domenig O, Poglitsch M, Lazartigues E (2017) Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension. Circ Res 121(1):43\u201355","journal-title":"Circ Res"},{"issue":"1","key":"92_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","volume":"76","author":"G Yang","year":"2020","unstructured":"Yang G, Tan Z, Zhou L, Yang M, Peng L, Liu J, Cai J, Yang R, Han J, Huang Y, He S (2020) Effects of angiotensin II receptor blockers and ACE (angiotensin-converting enzyme) inhibitors on virus infection, inflammatory status, and clinical outcomes in patients With COVID-19 and hypertension. Hypertens 76(1):51\u201358","journal-title":"Hypertens"},{"issue":"4","key":"92_CR48","first-page":"586","volume":"46","author":"H Zhang","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. ICM 46(4):586\u2013590","journal-title":"ICM"},{"issue":"6","key":"92_CR49","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","volume":"31","author":"L Zhu","year":"2020","unstructured":"Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, Lei F, Wang H, Xie J, Wang W, Li H, Zhang P, Song X, Chen X, Xiang M, Zhang C, Bai L, Xiang D, Chen M-M, Liu Y, Yan Y, Liu M, Mao W, Zou J, Liu L, Chen G, Luo P, Xiao B, Zhang C, Zhang Z, Lu Z, Wang J, Lu H, Xia X, Wang D, Liao X, Peng G, Ye P, Yang J, Yuan Y, Huang X, Guo J, Zhang B-H, Li H (2020) Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31(6):1068-1077.e3","journal-title":"Cell Metab"}],"container-title":["Biologia Futura"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42977-021-00092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42977-021-00092-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42977-021-00092-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:35:47Z","timestamp":1633944947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42977-021-00092-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1007\/s42977-021-00092-2","relation":{},"ISSN":["2676-8615","2676-8607"],"issn-type":[{"value":"2676-8615","type":"print"},{"value":"2676-8607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,8]]},"assertion":[{"value":"26 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Funding information section was missing from the HTML version of this article and should have read \u2018Open access funding provided by Semmelweis University.\u2019.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}